Shin Nippon Biomedical Laboratories, Ltd.
Status: Publicly traded
Direct answer
Shin Nippon Biomedical Laboratories, Ltd. is publicly traded on JPX under the ticker 2395.T.
Shin Nippon Biomedical Laboratories, Ltd. operates as a global contract research organization (CRO), delivering comprehensive drug discovery and development services both in Japan and internationally. Its preclinical offerings encompass a wide array of laboratory services, including regulatory-compliant good laboratory practice (GLP) inspections. These studies cover general and specialized toxicity assessments,...
Can you invest in Shin Nippon Biomedical Laboratories, Ltd.?
Yes. Shin Nippon Biomedical Laboratories, Ltd. trades publicly on JPX as 2395.T.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Shin Nippon Biomedical Laboratories, Ltd.
Detailed equity research is provided by MarketSnap.